Proposed Information Collection Activity; Center for States Evaluation Ancillary Data Collection (0970-0501), 30710-30711 [2020-10906]
Download as PDF
<![CDATA[
30710
Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios; and (5) review of
program proposals.
Matters To Be Considered: The open
portion of the agenda will include an
update on the formation of the BSC,
NCIPC Opioid Workgroup, a
presentation focused on opportunities
for stakeholder engagement on
management of acute and chronic pain,
and an update on the CDC Opioid
Prescribing Estimates Project. All
presentations will be followed by
discussion by the BSC. The closed
portion of the agenda will focus on the
secondary peer review of extramural
research grant applications received in
response to two (2) Notice of Funding
Opportunities (NOFOs): RFA–CE20–
001—‘‘Evaluating Practice-Based
Programs, Policies, and Practices from
CDC’s Rape Prevention and Education
(RPE) Program: Expanding the Evidence
to Prevent Sexual Violence’’; and RFA–
CE20–003—‘‘Research Grants for
Preventing Violence and ViolenceRelated Injury’’ (R01). Agenda items are
subject to change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–10891 Filed 5–19–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Center for States Evaluation
Ancillary Data Collection (0970–0501)
Children’s Bureau,
Administration on Children, Youth and
Families, Administration for Children
and Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the
collection of information under the
Center for States Evaluation Ancillary
Data Collection (OMB #0970–0501,
expiration date 8/31/2020) without
changes.
SUMMARY:
Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
ACF is soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
DATES:
forwarded by emailing infocollection@
acf.hhs.gov. Alternatively, copies can
also be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation (OPRE), 330 C Street
SW, Washington, DC 20201, Attn: ACF
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The Evaluation of the
Child Welfare Capacity Building
Collaborative, Center for States is
sponsored by the Children’s Bureau
(CB), ACF. The purpose of this
evaluation is to respond to a set of crosscutting evaluation questions posed by
CB. This existing information collection
is an ancillary part of a larger data
collection effort being conducted for the
evaluation of the Child Welfare Capacity
Building Collaborative (0970–0484 and
0970–0494). This notice details a group
of instruments that are specific only to
the Center for States. The instruments
focus on (1) evaluating an innovative
approach to engaging professionals in
networking and professional
development through virtual
conferences, (2) understanding fidelity
to and effectiveness of the Center for
States’ Capacity Building Model, and (3)
capturing consistent information during
the updated annual assessment process
focused on related contextual issues
impacting potential service delivery
such as implementation of new
legislation.
Respondents: Respondents of these
data collection instruments will include
child welfare agency staff and
stakeholders who directly receive
services.
ANNUAL BURDEN ESTIMATES
Total number
of respondents
Instrument
Child Welfare Virtual Conference:
Child Welfare Virtual Conference Session Surveys .....
Child Welfare Virtual Conference Focus Group Guide
Child Welfare Virtual Conference Interview Guide .......
Child Welfare Virtual Conference Registration Form ...
Child Welfare Virtual Conference Exit Survey .............
Tailored Services Capacity Building Approach:
Tailored Services Practice Model Survey ....................
Assessment Observation— Group Debrief ..................
Service Delivery and Tracking and Adjustment Observation—Group Debrief ..............................................
Assessment and Service Delivery State Lead Interviews—Supplemental Questions ..............................
Assessment questions:
Annual Assessment Update (8 systematic questions)
Total .......................................................................
VerDate Sep<11>2014
17:51 May 19, 2020
Jkt 250001
PO 00000
Total number
of responses
per
respondent
Average
burden hours
per response
Total burden
hours
Annual burden
hours
450
30
20
1000
225
6
1
1
1
1
.08
1
.5
.03
.16
216
30
10
30
36
72
10
3
10
12
130
50
1
1
.12
.25
15.6
12.5
5
4
80
1
.25
20
7
30
1
.5
15
5
54
1
.08
4.32
1
........................
........................
........................
........................
130
Frm 00029
Fmt 4703
Sfmt 4703
E:\FR\FM\20MYN1.SGM
20MYN1
Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: Section 203 of Section II:
Adoption Opportunities of the Child Abuse
Prevention and Treatment Act (CAPTA) (42
U.S.C. 5113).
Molly B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–10906 Filed 5–19–20; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–1155]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Food Labeling
Regulations
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Submit written comments
(including recommendations) on the
collection of information by June 19,
2020.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be submitted to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
Review—Open for Public Comments’’ or
by using the search function. All
comments should be identified with the
OMB control number 0910–0381. Also
include the FDA docket number found
SUMMARY:
VerDate Sep<11>2014
17:51 May 19, 2020
Jkt 250001
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Food Labeling Regulations
OMB Control Number 0910–0381—
Revision
This information collection supports
our food labeling regulations and
associated Agency guidance. Under the
authority of sections 4, 5, and 6 of the
Fair Packaging and Labeling Act (FPLA)
(15 U.S.C. 1453, 1454, and 1455) and
sections 201, 301, 402, 403, 409, 411,
701, and 721 of the Federal Food, Drug,
and Cosmetic Act (FD&C Act) (21 U.S.C.
321, 331, 342, 343, 348, 350, 371, and
379e), we have issued regulations
regarding the labeling of food. The
regulations are codified in parts 101,
102, 104, and 105 (21 CFR parts 101,
102, 104, and 105) and implement
statutory provisions that a food product
shall be deemed to be misbranded if,
among other things, its label or labeling
fails to bear certain required information
concerning the food product, is false or
misleading in any particular, or bears
certain types of unauthorized claims.
While part 101 sets forth general food
labeling provisions, requirements
pertaining to the common or usual name
for nonstandardized foods; guidelines
for nutritional quality to prescribe the
minimum level or range of nutrient
composition appropriate for a given
class of food; and requirements for foods
for special dietary use are found in parts
102, 104, and 105, respectively.
The disclosure requirements, along
with the reporting and recordkeeping
provisions, are necessary to ensure the
safety of food products produced or sold
in the United States and enable
consumers to be knowledgeable about
the foods they purchase. Nutrition
labeling provides information for use by
consumers in selecting a nutritious diet.
Other information enables consumers to
comparison shop. Ingredient
information also enables consumers to
avoid substances to which they may be
sensitive. Petitions or other requests
submitted to us provide the basis for us
to permit new labeling statements or to
grant exemptions from certain labeling
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
30711
requirements. Recordkeeping
requirements enable us to monitor the
basis upon which certain label
statements are made for food products
and whether those statements are in
compliance with the requirements of the
FD&C Act or the FPLA.
Specifically, the regulations set forth
the general content and format
requirements for food packaging,
including nutrition and ingredient
information. Additional regulations
provide for nutrient content claims. To
assist respondents in this regard, we
developed the document entitled
‘‘Guidance for Industry: Notification of
a Health Claim or Nutrient Content
Claim Based on an Authoritative
Statement of a Scientific Body.’’ The
guidance is available from our website
at: https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments/guidance-industrynotification-health-claim-or-nutrientcontent-claim-based-authoritativestatement. The guidance communicates
our recommendations regarding food
labeling claims associated with
regulations found in §§ 101.13, 101.14,
101.54, 101.69, and 101.70. It was
developed to assist respondents in
satisfying criteria found or discussed in
these regulations regarding the
submission of notifications for certain
health claims and identifies information
to include and information we will
evaluate in determining compliance
with statutory requirements (e.g.,
supporting literature; discussion of
analytical methodology or
methodologies used in support of a
particular claim).
The regulations also include
provisions applicable to the labeling of
dietary supplements. To assist
respondents in this regard and in
understanding provisions under the
Dietary Supplement and
Nonprescription Drug Consumer
Protection Act (Pub. L. 109–462), we
developed the guidance entitled
‘‘Questions and Answers: Labeling of
Dietary Supplements as Required by the
Dietary Supplement and
Nonprescription Drug Consumer
Protection Act.’’ The guidance is
available from our website at: https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents/
guidance-industry-questions-andanswers-regarding-labeling-dietarysupplements-required-dietary. The
guidance communicates the following
information: (1) What ‘‘domestic
address’’ means for purposes of the
dietary supplement labeling
requirements in section 403(y) of the
FD&C Act; (2) FDA’s recommendation
for the use of an introductory statement
E:\FR\FM\20MYN1.SGM
20MYN1
]]>Agencies
[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30710-30711]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10906]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Center for States
Evaluation Ancillary Data Collection (0970-0501)
AGENCY: Children's Bureau, Administration on Children, Youth and
Families, Administration for Children and Families, HHS.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) is
requesting a 3-year extension of the collection of information under
the Center for States Evaluation Ancillary Data Collection (OMB #0970-
0501, expiration date 8/31/2020) without changes.
DATES: Comments due within 60 days of publication. In compliance with
the requirements of Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995, ACF is soliciting public comment on the specific aspects
of the information collection described above.
ADDRESSES: Copies of the proposed collection of information can be
obtained and comments may be forwarded by emailing
[email protected]. Alternatively, copies can also be obtained
by writing to the Administration for Children and Families, Office of
Planning, Research, and Evaluation (OPRE), 330 C Street SW, Washington,
DC 20201, Attn: ACF Reports Clearance Officer. All requests, emailed or
written, should be identified by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: The Evaluation of the Child Welfare Capacity Building
Collaborative, Center for States is sponsored by the Children's Bureau
(CB), ACF. The purpose of this evaluation is to respond to a set of
cross-cutting evaluation questions posed by CB. This existing
information collection is an ancillary part of a larger data collection
effort being conducted for the evaluation of the Child Welfare Capacity
Building Collaborative (0970-0484 and 0970-0494). This notice details a
group of instruments that are specific only to the Center for States.
The instruments focus on (1) evaluating an innovative approach to
engaging professionals in networking and professional development
through virtual conferences, (2) understanding fidelity to and
effectiveness of the Center for States' Capacity Building Model, and
(3) capturing consistent information during the updated annual
assessment process focused on related contextual issues impacting
potential service delivery such as implementation of new legislation.
Respondents: Respondents of these data collection instruments will
include child welfare agency staff and stakeholders who directly
receive services.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Total number Average burden
Instrument Total number of responses hours per Total burden Annual burden
of respondents per respondent response hours hours
----------------------------------------------------------------------------------------------------------------
Child Welfare Virtual
Conference:
Child Welfare Virtual 450 6 .08 216 72
Conference Session Surveys.
Child Welfare Virtual 30 1 1 30 10
Conference Focus Group
Guide......................
Child Welfare Virtual 20 1 .5 10 3
Conference Interview Guide.
Child Welfare Virtual 1000 1 .03 30 10
Conference Registration
Form.......................
Child Welfare Virtual 225 1 .16 36 12
Conference Exit Survey.....
Tailored Services Capacity
Building Approach:
Tailored Services Practice 130 1 .12 15.6 5
Model Survey...............
Assessment Observation-- 50 1 .25 12.5 4
Group Debrief..............
Service Delivery and 80 1 .25 20 7
Tracking and Adjustment
Observation--Group Debrief.
Assessment and Service 30 1 .5 15 5
Delivery State Lead
Interviews--Supplemental
Questions..................
Assessment questions:
Annual Assessment Update (8 54 1 .08 4.32 1
systematic questions)......
-------------------------------------------------------------------------------
Total................... .............. .............. .............. .............. 130
----------------------------------------------------------------------------------------------------------------
[[Page 30711]]
Comments: The Department specifically requests comments on (a)
whether the proposed collection of information is necessary for the
proper performance of the functions of the agency, including whether
the information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Authority: Section 203 of Section II: Adoption Opportunities of
the Child Abuse Prevention and Treatment Act (CAPTA) (42 U.S.C.
5113).
Molly B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020-10906 Filed 5-19-20; 8:45 am]
BILLING CODE 4184-01-P
